Cobenfy patent?

Do you mean Cobenfy (xanomeline/trospium)? If so, here’s the general patent landscape—but note I can’t see live patent databases from here, so consider this as guidance and I can help you verify specific filings if you share a link or jurisdiction (US/EU/WO).

What “Cobenfy patent” usually refers to

For a drug like Cobenfy, “patent coverage” typically comes from a mix of:

1. Active ingredient composition patents (xanomeline + trospium, and/or specific crystalline forms/ratios)
2. Formulation patents (tablet/extended-release form, excipients, manufacturing method)
3. Method-of-use patents (treating schizophrenia or other indications with that regimen)
4. Process patents (how the drug is made)
5. Patent term extensions and regulatory exclusivities (depending on country)

How to find the exact patents (best way)

If you tell me which country you mean, I can walk you through the exact steps. Common sources:

• USPTO / Google Patents (US)
• Espacenet / EPO register (EU)
• WIPO / Patentscope (WO/PCT)

Search terms to use:

• “xanomeline trospium”
• “Cobenfy”
• “xanomeline trospium composition patent”
• Company name (if you have it—often it’s KarXT-related for xanomeline products, but confirm for Cobenfy)

If you want, I can be very specific

Reply with:

1. Country/jurisdiction (US, EU, UK, etc.)
2. Any detail you have (company name, a patent number, or a label like “US patent …”)
3. Whether you want expiration date, which patents are blocking generics, or just a summary

…and I’ll help you pinpoint the relevant patents and what they cover.